The effects of GLP-1RA treatment on graft steatosis development, body weight changes, and glycemic control were compared to those of insulin in a 1:1 matched series of 38 LT recipients by Yakubu et al. [28] in a retrospective single-center study. This evidence concerns the gene INS and steatosis.